Frequently Asked Questions
The market is segmented based on Europe Point of Care Testing (POCT) Device Market, By Product Type (Blood Glucose Testing Kits, Cardio Metabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy and Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing kits, and Others), Prescription (Prescription Based Testing and Over-The-Counter (OTC) Testing), Distribution Channel (Direct Tenders and Retail), End Users (Hospital, Clinics, Ambulatory Care, Home Healthcare, and Research Laboratory) , Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, and Rest of Europe.) Industry Trends and Forecast to 2029.
.
The Europe Poct Device Market size was valued at USD 0.00 USD Million in 2022.
The Europe Poct Device Market is projected to grow at a CAGR of 9.3% during the forecast period of 2023 to 2029.
The major players operating in the market include Abbott, Abaxis, PTS Diagnostics, F. Hoffmann-La Roche Ltd, Samsung Medison Co. Ltd, Bio-Rad Laboratories , The Menarini Group, and others,.
